Mahesh Karande

Mahesh Karande is currently a Director at Ashvattha Therapeutics Inc since 2023 and a Director at KSQ Therapeutics, Inc. since 2022.
Previously, he held the position of President & Chief Executive Officer at Zikani Therapeutics, Inc. from 2018 to 2019, President, Chief Executive Officer & Director at Omega Therapeutics, Inc. from 2019 to 2024, Vice President & Head-US Oncology at Novartis, Inc. from 2010 to 2017, President at Novartis SA from 2010 to 2017, and President at Novartis Pharma SAE from 2010 to 2017.
Mr. Karande has a graduate degree from Georgia Institute of Technology, an undergraduate degree from the University of Mumbai, and an MBA from The Wharton School of the University of Pennsylvania.